| [1] |
MALAGUARNERA M,CRISTALDI E,ROMANO G,et al.Autoimmunity in the elderly:implications for cancer[J].J Cancer Res Ther,2012,8(4):520-527.
|
| [2] |
茹晋丽,赵越,张莉芸,等. 抗细胞膜DNA抗体检测方法的建立及对系统性红斑狼疮诊断价值的临床应用研究[J]. 中华风湿病学杂志,2012,16(1):27-32.
|
| [3] |
YOSHIO T,ONDA K,NARA H,et al.Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus[J].Arthritis Rheum,2006,54(2):675-678.
|
| [4] |
YANG Y,YUAN C,SHEN S Q,et al.Autoantibodies to NR2A peptide of the glutamate/NMDA receptor in patients with seizure disorders in neuropsychiatric systemic lupus erythematosus[J]. Mediators Inflamm,2017,2017:5047898.
|
| [5] |
ABEDIAN Z,SAGAFI M,KENARI S A,et al. Anti-perinuclear factor as diagnostic marker in rheumatoid arthritis[J]. J Clin Diagn Res,2015,9(9):OC13-OC16.
|
| [6] |
李敬扬,周伦祥,易晴松,等. 抗核周因子、抗角蛋白抗体与类风湿因子联合检测在类风湿关节炎中的意义[J]. 中国现代医学杂志,2006,16(13):1996-1999.
|
| [7] |
STEINER G,SMOLEN J.Autoantibodies in rheumatoid arthritis and their clinical significance[J].Arthritis Res,2002,4(Suppl 2):S1-S5.
|
| [8] |
裴春红,赵春生.多指标联合检测在类风湿关节炎诊断中的临床价值分析[J].中国医学创新,2012,5(32):92.
|
| [9] |
AL-MUGHALES J A. Immunodiagnostic significance of anti-RA33 autoantibodies in Saudi patients with rheumatoid arthritis[J]. J Immunol Res,2015,2015:604305.
|
| [10] |
VOSSENAAR E R,DESPRES N,LAPOINTE E,et al.Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin[J].Arthritis Res Ther,2004,6(2):R142-R150.
|
| [11] |
RENGER F,BANG H,FEIST E,et al.Immediate determination of ACPA and rheumatoid factor-a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral- flow immunoassay[J].Arthritis Res Ther,2010,12(3):R120.
|
| [12] |
SIZOVA L.Diagnostic value of antibodies to modified citrullinated vimentin in early rheumatoid arthritis[J].Hum Immunol,2012,73(4):389-392.
|
| [13] |
ZAHRAN W E,MAHMOUD M I,SHALABY K A,et al.Unique correlation between mutated citrullinated vimentin IgG autoantibodies and markers of systemic inflammation in rheumatoid arthritis patients[J]. Indian J Clin Biochem,2013,28(3):272-276.
|
| [14] |
CHOI S W,LIM M K,SHIN D H,et al.Diagnostic performances of anti-cyclic citrullinated peptides antibody and antifilaggrin antibody in Korean patients with rheumatoid arthritis[J].J Korean Med Sci,2005,20(3):473-478.
|
| [15] |
DUBUCQUOI S,SOLAU-GERVAIS E,LEFRANC D,et al.Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases[J].Ann Rheum Dis,2004,63(4):415-419.
|
| [16] |
SHI J,KNEVEL R,SUWANNALAI P,et al.Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage[J]. Proc Natl Acad Sci U S A,2011,108(42):17372-17377.
|
| [17] |
YEE A,WEBB T,SEAMAN A,et al.Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis[J]. Immunol Res,2015,61(1-2):24-30.
|
| [18] |
KAJIYA M,ICHIMONJI L,MIN C,et al.Muscarinic type 3 receptor induces cytoprotective signaling in salivary gland cells through epidermal growth factor receptor transactivation[J].Mol Pharmacol,2012,82(1):115-124.
|
| [19] |
罗慧臣,李萍,肖卫国.M3R与AQP5在干燥综合征患者唇腺中的表达与意义[J].中国免疫学杂志,2011,27(1):79-81.
|
| [20] |
SHEN L,SURESH L,MALYAVANTHAM K,et al.Different stages of primary Sjögren's syndrome involving lymphotoxin and type 1 IFN[J]. J Immunol,2013,191(2):608-613.
|
| [21] |
SHEN L,SURESH L,LI H,et al.IL-14 alpha,the nexus for primary Sjögren's disease in mice and humans[J].Clin Immunol,2009,130(3):304-312.
|
| [22] |
VISHWANATH S,EVERETT S,SHEN L,et al.Xerophthalmia of Sjögren's syndrome diagnosed with anti-salivary gland protein 1 antibodies[J].Case Rep Ophthalmol,2014,5(2):186-189.
|
| [23] |
WATANABE T,TSUCHIDA T,KANDA N,et al.Anti-alpha-fodrin antibodies in Sjören syndrome and lupus erythematosus[J]. Arch Dermatol,1999,135(5):535-539.
|
| [24] |
HE J,FANG W,LI Z G.The application of combined detection of autoantibodies in primary Sjögren's syndrome[J].Zhonghua Nei Ke Za Zhi,2008,47(5):366-368.
|
| [25] |
ZANDBELT M M,VOGELZANGS J,VAN D E PUTTE L B,et al.Anti-alpha-fodrin antibodies do not add much to the diagnosis of Sjögren's syndrome[J].Arthritis Res Ther,2004,6(1):R33-R38.
|
| [26] |
SORDET C,GOTTENBERG J E,GOETZ J,et al.Anti-alpha-fodrin autoantibodies are not useful diagnostic markers of primary Sjögren's syndrome[J]. Ann Rheum Dis,2005,64(8):1244-1245.
|
| [27] |
DUGAR M,COX S,LIMAYE V,et al.Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies[J].Intern Med J,2011,41(9):674-679.
|
| [28] |
MARIE I,LAHAXE L,BENVENISTE O,et al.Long-term outcome of patients with polymyositis/dermatomyositis and anti-PM-Scl antibody[J].Br J Dermatol,2010,162(2):337-344.
|
| [29] |
FUJIMOTO M,MURAKAMI A,KUREI S,et al.Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis[J]. J Dermatol Sci,2016,84(3):272-281.
|
| [30] |
张健,宋芹,常虹,等. 多发性肌炎/皮肌炎患者血清抗Jo-1和Mi-2等6种自身抗体检测的意义[J].中国误诊学杂志,2008,8(23):5548-5550.
|
| [31] |
HAMAGUCHI Y,KUWANA M,HOSHINO K,et al.Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis:a multicenter cross-sectional study[J].Arch Dermatol,2011,147(4):391-398.
|
| [32] |
SATO S,KUWANA M,FUJITA T,et al.Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease[J]. Mod Rheumatol,2013,23(3):496-502.
|
| [33] |
HOSHINO K,MUM Y,SUGIURA K,et al.Anti-MDA5 and anti-TIFI-gamma antibodies have clinical significance for patients with dermatomyositis[J].Rheumatology(Oxford),2010,49(9):1726-1733.
|
| [34] |
TARGOFF I N,MAMYROVA G,TRIEU E P,et al.A novel autoantibody to a 155-kd protein is associated with dermatomyositis[J].Arthritis Rheum,2006,54(11):3682-3689.
|
